393 related articles for article (PubMed ID: 27365407)
1. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
[TBL] [Abstract][Full Text] [Related]
3. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm.
Boersema J; de Vos LC; Links TP; Mulder DJ; Smit AJ; Zeebregts CJ; Lefrandt JD
J Vasc Surg; 2017 Dec; 66(6):1696-1703.e1. PubMed ID: 28655550
[TBL] [Abstract][Full Text] [Related]
4. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
de Vos LC; Mulder DJ; Smit AJ; Dullaart RP; Kleefstra N; Lijfering WM; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):933-8. PubMed ID: 24526694
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
[TBL] [Abstract][Full Text] [Related]
6. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2356-63. PubMed ID: 21885790
[TBL] [Abstract][Full Text] [Related]
9. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
Shardlow A; McIntyre NJ; Kolhe NV; Nellums LB; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2020 Jul; 17(7):e1003163. PubMed ID: 32658890
[TBL] [Abstract][Full Text] [Related]
10. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
11. Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank.
Jin Q; Lau ES; Luk AO; Ozaki R; Chow EY; So T; Yeung T; Loo KM; Lim CK; Kong AP; ; So WY; Jenkins AJ; Chan JC; Ma RC
Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):436-446. PubMed ID: 34895800
[TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Chonchol M; Gitomer B; Isakova T; Cai X; Salusky I; Pereira R; Abebe K; Torres V; Steinman TI; Grantham JJ; Chapman AB; Schrier RW; Wolf M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1461-1469. PubMed ID: 28705885
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
[TBL] [Abstract][Full Text] [Related]
16. High Urinary Aspartate Aminotransferase in the Late Posttransplant Period Predicts Rapid, Progressive Decline in Kidney Allograft Function.
Trailin AV; Pleten MV; Ostapenko TI; Iefimenko NF; Nikonenko OS
Exp Clin Transplant; 2017 Jun; 15(3):267-276. PubMed ID: 28332956
[TBL] [Abstract][Full Text] [Related]
17. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
[TBL] [Abstract][Full Text] [Related]
18. Relationship between kidney disease and endothelial function in peripheral artery disease.
Chong KC; Owens CD; Park M; Alley HF; Boscardin WJ; Conte MS; Gasper WJ; Grenon SM
J Vasc Surg; 2014 Dec; 60(6):1605-11. PubMed ID: 25441679
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
